The Weight Loss Drug Revolution: GLP-1 RA drugs inspire new excitement for metabolic bariatric surgeons
Proponents say the surgical procedures are underutilized and misunderstood in contemporary medicine.
The Weight Loss Drug Revolution: Helping patients avoid phony medicine scams
With high demand but high prices for antiobesity drugs, patients may fall for phony pharmaceuticals.
A new definition of obesity is needed, expert analysts say
Clinical and preclinical are distinctions that could guide patient treatment, public health and medical policy going forward, according to study commission.
Best diets of 2025 – how and what to eat for a healthy year
It’s not too late to make a new year’s resolution to eat better. Here’s some good advice on eating for patients and physicians.
How to make 2025 a good year for brain health
A slideshow with conversation starters for physicians and patients to evaluate factors affecting brain health at the start of a new year.
GLP-1 RA drugs and primary care: What do physicians need to know?
Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.
GLP-1 RA antiobesity medications: Predictions for the future
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
GLP-1 RA antiobesity medications: Long-term safety
GLP-1 RA antiobesity medications: Learning about side effects, and managing them
GLP-1 RA antiobesity medications: Lifestyle changes needed too
GLP-1 RA antiobesity medications: Talking about cost
GLP-1 RA antiobesity medications: Patients’ No. 1 question
Medicare announces 2026 plan to cover antiobesity medications
Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.
GLP-1 RA antiobesity medications: a new panacea?
GLP-1 RA antiobesity medications: an introduction
Medication alone will not end obesity
Obesity is a complex disease that requires treatment both individualized and multifaceted.
Ozempic, Wegovy are miracle drugs priced out of reach of patients, senators say
Senate HELP Committee grills Novo Nordisk CEO over prices of Ozempic, Wegovy. He says patients not getting needed medicines is ‘terrifying.’
Risk in scientific experimentation; bariatric surgery parameters; ‘generally recognized as safe’ (we hope) – Morning Medical Update
The top news stories in medicine today.
Bias in treating pain; facial reconstruction; eat well, stress less – Morning Medical Update
Reasoning against physician-assisted suicide; helping healthy eating; bogus weight-loss drugs – Morning Medical Update
Primary care in crisis; updating asbestos research; inspiring others – Morning Medical Update
7 tips for improving senior obesity care
These tips could remove the barriers between quality obesity care and older adults.
Guidelines on women’s health; tracking diversity in health care; putting a face to the ransomware – Morning Medical Update
Avian flu spreads; stairway to health; protecting health data – Morning Medical Update
Healthy lunches for students; mechanical bull risks; medical fraudster on the lam – Morning Medical Update
ACP recommends pharmacologic treatments for Type 2 diabetes
Reducing risks of all-cause mortality is a goal with new treatment options.
Global fertility and population; royal cancer diagnosis; advocating for avocados – Morning Medical Update
Medicare Part D to cover cost of Wegovy when used to reduce risks of heart conditions
CMS issues guidance and won’t pay for the drug for weight loss exclusively.
Helping patients attain optimal wellness requires allies
Primary care physicians and their patients know broad rules for good health, but those can be overwhelming without personal assistance to integrate the principles into daily life.
Antiobesity medicines can help patients, but health professionals must consider food and body needs
Academy of Nutrition and Dietetics president discusses latest trends in food, patient health and medicine.
